A detailed history of Stenger Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stenger Family Office, LLC holds 11,872 shares of ABBV stock, worth $2.29 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
11,872
Holding current value
$2.29 Million
% of portfolio
0.72%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$164.99 - $203.87 $1.96 Million - $2.42 Million
11,872 New
11,872 $2.11 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Stenger Family Office, LLC Portfolio

Follow Stenger Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stenger Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stenger Family Office, LLC with notifications on news.